ForCast Orthopedics and Koru Medical (KRMD) jointly announced an agreement leveraging Koru Medical’s FreedomEdge infusion system as part of ForCast’s technology platform for the treatment of periprosthetic joint infection.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
- Strategic Growth and Innovation Drive Buy Rating for REPRO-MED Systems
- KORU Medical Systems Reports Strong Q2 2025 Growth
- REPRO-MED Systems: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
- Koru Medical price target raised to $4 from $3.50 at Piper Sandler
- KORU Medical Systems Reports Record Q2 2025 Results